![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
. | ![]() |
. |
![]() by Staff Writers London, UK (SPX) Nov 03, 2017
A research collaboration has discovered a new way of rapidly generating a swathe of medically significant natural products after discovering a ground-breaking technique that turns the marathon of evolution into a sprint. The surprise discovery came when the research team inadvertently replicated a process that bacteria use to evolve their machinery for making natural products. Now the team, which includes scientists at the John Innes Centre, plan to harness this process to generate "libraries" of valuable compounds created from the technique which they have named Accelerated Evolution. "For 20 years we have been using rational bioengineering to modify the chemical structures of clinically important natural products - using genetics to make a new molecule in a process that parallels medicinal chemistry - and that's what we were doing when we stumbled upon this," said Professor Barrie Wilkinson from the John Innes Centre. "We have discovered a completely new way of doing things, one that will also teach us how to better bioengineer systems in a rational manner." The collaboration was led by Isomerase Therapeutics Ltd, and included the University of Cambridge, Pfizer, Roche and DSTL. The team were involved in lab work to produce new versions of rapamycin, a commercially successful natural compound produced by bacteria, used to prevent organ transplant rejection and treat certain cancers. Rapamycin belongs to a medically and agriculturally important class of compounds called Polyketides. Fungi and bacteria produce these compounds to give them a survival advantage, for example to defend against pathogen attack and secure resources in the environment. As part of their experiment, the team inserted a temperature sensitive replicon into the genome of the host strain, the soil bacteria Streptomyces rapamycinicus. But instead of the expected result - a new Streptomyces rapamycinicus strain producing a specific new version of rapamycin - they isolated a wide range of new strains that each produced unexpected new molecules. These strains could be further modified leading to hundreds of new, structurally diverse compounds. The team believe that, by inserting the replicon into the genes responsible for making rapamycin, they inadvertently introduced a genetic instability which activated a DNA repair process called homologous replication. This caused the host bacteria to "spit" out the replicon from the genome, causing a rearrangement of the rapamycin biosynthetic genes. Professor Wilkinson explains: "We think this process mimics and accelerates the processes that are prevalent during natural polyketide evolution." By setting up a drug discovery development platform to harness the Accelerated Evolution platform, the team believes it is at the beginning of a new age in natural product drug discovery. Dr Matthew Gregory, a corresponding author of the paper and CEO of Isomerase Therapeutics Ltd, said: "The work described in this paper has important ramifications for the natural products field and synthetic biology generally."
Research Report: Diversity oriented biosynthesis via accelerated evolution of modular gene clusters
![]() Washington (UPI) Oct 31, 2017 New research suggests the social lives of orphaned elephants are significantly altered by the loss of their mothers to poaching. The maturation process for young elephants in highly social, closely knit communities is reliant upon the relationships between calves and their moms and aunts. Poaching can disrupt these social relationships and a new study - published this week in the journ ... read more Related Links John Innes Centre Darwin Today At TerraDaily.com
![]()
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |